Three pharmaceutical companies probed for excessive pricing of cancer drugs

Three pharmaceutical companies are being investigated by the Competition Commission for suspected excessive pricing of their cancer drugs.

The three companies are generic drug maker Aspen Pharmacare, Roche and Pfizer.

Deputy commissioner at the Competition Commission, Hardin Ratshisusu, says affordability of cancer drugs is an imperative.

We have been looking into this matter and we have now settled to initiate an investigation into these three companies.

Hardin Ratshisusu, Deputy Commissioner

These are separate investigations but they all cut across the cancer drugs

Hardin Ratshisusu, Deputy Commissioner

According to Ratshisusu, Pfizer will be investigated for a particular drug that treats cancer, for Roche they will be probing for a drug that treats breast cancer and for Aspen, a drug that treats leukemia.

We have information that points to potential exploitation by these companies, their prices are extremely excessive.

Hardin Ratshisusu, Deputy Commissioner

The official investigation was initiated on Tuesday, says Ratshisusu.

To hear more about this investigation into these three pharmaceutical companies, listen below:


This article first appeared on CapeTalk : Three pharmaceutical companies probed for excessive pricing of cancer drugs


Recommended

by NEWSROOM AI
Read More
‘Aspen Pharmacare discussed destruction of life-saving drugs to drive up prices'

‘Aspen Pharmacare discussed destruction of life-saving drugs to drive up prices'

The South African drug maker also failed to disclose its 2016 €5.2-million Italian competition authority fine for price gouging.

The rise in the use of cough syrup as a drug in focus

The rise in the use of cough syrup as a drug in focus

Lorraine Osman, Pharmaceutical SA, says it’s easy to become addicted to cough syrup because of the drug codeine.

Zuma announces state-owned pharmaceutical company

Zuma announces state-owned pharmaceutical company

President Zuma shared the way forward for South Africa at SONA 2016, particularly in the fields of education and health.

3 best shares to buy at the start of 2016 (according to Vestact)

3 best shares to buy at the start of 2016 (according to Vestact)

You won't be too surprised by the usual suspects Vestact Portfolio Manager Michael Treherne chooses as stock picks of the week.

South African pharma-giant Aspen Group making good money abroad

South African pharma-giant Aspen Group making good money abroad

Aspen Group released results saying the international business delivered 49% of gross revenue.

Popular articles
Gigaba implicated in Transnet impropriety

Gigaba implicated in Transnet impropriety

Gigaba has been fingered in a forensic investigation related to the procurement process for locomotives from China South Rail.

[LISTEN] Cervical cancer is the only cancer that is caused by sex - Dr Eve

[LISTEN] Cervical cancer is the only cancer that is caused by sex - Dr Eve

Dr Eve discusses cervical cancer and how it can be prevented.

[LISTEN] Is Gqom really music? Callers share their views

[LISTEN] Is Gqom really music? Callers share their views

Callers on the open line discuss class appropriation by musicians and music genres.

Angry customer stops at nothing to expose bad service at upmarket hotel

Angry customer stops at nothing to expose bad service at upmarket hotel

Khabazela shares some of the most popular tweets, posts, and videos on 'What's gone Viral'.

3 risks to your retirement savings (and how to mitigate each of them)

3 risks to your retirement savings (and how to mitigate each of them)

Only 5% of South African retirement fund members will retire comfortably. Bruce Whitfield interviews advisor Warren Ingram.

Gift of the Givers' Dr Imtiaz Sooliman – angel amongst men – talks about money

Gift of the Givers' Dr Imtiaz Sooliman – angel amongst men – talks about money

"I have no desire for clothes. I have no desire for holidays. I have no desire for outings. All I see is the suffering of people…"

Discovery Bank takes on Capitec Bank, TymeDigital (Patrice Motsepe), Bank Zero

Discovery Bank takes on Capitec Bank, TymeDigital (Patrice Motsepe), Bank Zero

South Africa has a brand-new bank! The Money Show’s Bruce Whitfield interviews Adrian Gore, Discovery Group CEO.

Telkom 947 cycle challenge road closures update

Telkom 947 cycle challenge road closures update

Joburg motorists are urged to take note of road closures during the 2018 Telkom 947 Cycle Challenge.